Oral administration of lactate has been found to enhance the expression of tight junction proteins, including Claudin-1, ZO-1, and Occludin, through GPR81, thereby alleviating experimental colitis and inhibiting the NF-κB/MMP9 signaling pathway (Li et al., 2024). The gene discussed is HCAR1; the disease is colitis.